Skip to content

Effects of Ground-based Walking Training in Pulmonary Hypertension

A Randomized Controlled Trial of Ground-based Walking Training for Adult Patients With Pulmonary Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03762577
Enrollment
24
Registered
2018-12-03
Start date
2018-12-10
Completion date
2020-03-04
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension

Keywords

Pulmonary Hypertension, Walking Training, Exercise, Balance, Quality of Life

Brief summary

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in pulmonary artery pressure ≥25 mmHg when measured at resting with symptoms such as dyspnea, fatigue, chest pain, and syncope. PH characterized by decreased exercise capacity, quality of life, peripheral muscle strength, balance, and physical inactivity. It is recommended that patients with PH should be included in cardiopulmonary rehabilitation programs in addition to medical treatment. Ground-based walking training is a safe and effective method for COPD patients. In the literature, there are no studies evaluating the effects of ground-based walking training in PH patients.

Detailed description

The aim of this project is to determine the effect of ground-based walking training on physical activity, exercise capacity, balance, peripheral muscle strength and quality of life in patients with PH.

Interventions

Patients will attend a 2-day 30-minute ground-based walking training under the supervision of a physiotherapist. Patients will walk for 1-2 days in a week without supervision. According to the Modified Borg Scale, the dyspnea intensity will be 3-4 (medium to slightly difficult) and the heart rate will be completed to not exceed 120 min / pulse. Heart rate of patients will be followed by finger type pulse oximeter

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years * Diagnosed with PH * Followed by the department of chest diseases at least six months * Not participating in the rehabilitation program in last year

Exclusion criteria

* Functional group four due to WHO functional classification * PH due to left heart diseases, PH due to lung diseases and/or hypoxia * Treatment and medication change in the last three months * Cooperation problems * Patients with successful pulmonary endarterectomy operation * Smoking * Patients with uncontrolled cardiovascular diseases * Patients with orthopeadic and/or neurologic disorders that could limit exercise tests * Syncope history in recent

Design outcomes

Primary

MeasureTime frameDescription
Endurance exercise capacity8 weeksendurance shuttle walk test

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026